Abbott Laboratories ABT
NYSE ABT
$110.53 +0.58 (+0.53%)
At close: Nov 9, 2026 · 4:00 PM EST

Abbott Laboratories (ABT) Operating Leases (2019 - 2021)

Updated

Abbott Laboratories' Operating Leases was $956 million in Q4 2021, up 6.0% from $902 million a year earlier.

Analysis

Abbott Laboratories (ABT) Operating Leases (2019 - 2021) Analysis & Trends

  • In earlier years, Operating Leases was $902 million in FY2020 (+19.5%) and $755 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Agilent Technologies 50.79 Bn 43.67 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 956.00 Mn
Dec 31, 2020 902.00 Mn
Dec 31, 2019 755.00 Mn
API Access

Abbott Laboratories Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ABT&period=max&api_key=YOUR_API_KEY